About US
Contact us
-
With FDA settlement, tiny Amarin creates opening for pharma in off-label marketingMany of the Big Pharma players have paid hundreds of millions, sometimes billions, of dollars to settle federal litigation accusing them of pushing their products for unapproved uses. Now tiny Amarin2016/3/9
-
WHO recommends measures to prevent Zika virusThe World Health Organisation (WHO) has reported increasing evidence that the Zika virus is responsible for the cause of microcephaly and other neurological disorders. As a result, WHO has made certa2016/3/9
-
AstraZeneca to sell European rights of Moventig to ProStrakanAstraZeneca has agreed to sell the European rights for its peripherally-acting, mu-opioid receptor antagonist (PAMORA) Moventig to ProStrakan Group. Moventig is the first once-daily, oral Pamora appr2016/3/8
-
Teva Pharmaceutical acquires Mexico's Rimsa for $2.3bnTeva Pharmaceutical Industries has acquired a Mexican pharmaceutical manufacturing and distribution company Representaciones e Investigaciones Médicas (Rimsa) for $2.3bn. Plans for the deal were anno2016/3/8
-
J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nodJohnson & Johnson ($JNJ) and AbbVie ($ABBV) have snagged the indication for standout cancer med Imbruvica that they've been waiting for. On Friday, the FDA granted the pair a first-line nod in ch2016/3/7
-
Roche looks beyond Tamiflu, striking deal for Shionogi's flu fighterRoche's ($RHHBY) sometimes-blockbusterTamifluis one of only a couple of drugs approved for fighting influenza. But with generic competition brewing for the drug, the Swiss drugmaker is looking to the2016/3/7
-
Omalizumab drug can be better targeted to treat people with severe asthmaAround five million people in the UK are currently being treated for asthma. Of these, a quarter of a million are unable to get good control of their condition, resulting in frequent, severe, or even2016/3/3
-
Bass associate accuses PTO officials of bias against their pharma patent crusadeHedge funderKyle Bassand his Coalition for Affordable Drugs has been somewhat successful at using a new type of patent challenge to push review of "questionable" drug patents. But Bass' partner in tha2016/3/3
-
Digital health: the future for medicine?"The best way to predict the future is to invent it," these were the words of Alan Kay quoted by Dr Euan Ashley at the Recent Developments in Digital Health 2016 event at the Royal Society of Medicine2016/3/1
-
Are we ageing healthily? An interview with Professor Carol JaggerWith population ageing occurring in many countries, are rises in life expectancy resulting in increases in good quality years of life? This is the million dollar question but it is hard to give a def2016/3/1